NL-OMON50577已完成不适用
actoferrin in the treatment of Long COVID - LARGO-study
ongziekten0 个研究点目标入组 72 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Subjects aged 18-70 years with proven COVID-19 (positive COVID-19
- •RT-PCR- or antibody test)
- •- Persistent or newly developed long COVID symptoms at least 12 weeks
- •post-primary SARS-CoV-2 infection
- •- Patients with a positive COVID-19 RT-PCR- or antibody test not older than 9
排除标准
- •- Patients admitted to the ICU (COVID-19-related)
- •- COVID-19-related cardiac or pulmonary tissue damage
- •- Acute infection or current systemic immunological disorders
- •- Oral and/or inhaled use of corticosteroids or use of other immune-modulatory
- •- Current psychiatric disorders
- •- Communication difficulties
- •- Pregnant or lactating women
- •- Age >70 years
- •- Patients with milk allergy or a known or suspected allergy or any
- •contraindications to lactoferrin or microcrystalline cellulose (lactoferrin can
- •be used by individuals with lactose intolerance)
研究者
相似试验
招募中
不适用
actoferrin in the treatment of Long COVIDong COVIDNL-OMON21473Stichting O&O Franciscus Gasthuis & Vlietland72
Unknown
4 期
Antihistamines for treatment of Long COVIDCTRI/2022/07/043679Dr Arjun M C8
已完成
3 期
Effect of interfron in the treatment of covidCovid pneumonia.Coronavirus as the cause of diseaseB97.2IRCT20230930059562N1Imam hossein hospital80
招募中
3 期
actolyze studyDiarrhea and MalnutritionPACTR202108480098476ational Institute of Health600
进行中（未招募）
不适用
Study of Edaravone as adjunctive treatment in COVIDCTRI/2020/10/028472Sparsh Foundation